Blueprint Medicines shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Farallon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $349k | 4.0k | 87.22 |
| 2024-09-30 | $370k | 4.0k | 92.50 |
| 2024-06-30 | $431k | 4.0k | 107.78 |
| 2024-03-31 | $379k | 4.0k | 94.86 |
| 2023-09-30 | $201k | 4.0k | 50.22 |
| 2023-06-30 | $1.4M | 22k | 63.20 |
| 2023-03-31 | $1.0M | 22k | 44.99 |
| 2022-12-31 | $4.1M | 94k | 43.81 |
| 2022-06-30 | $61M | 1.2M | 50.51 |
| 2022-03-31 | $87M | 1.4M | 63.88 |
| 2021-12-31 | $87M | 812k | 107.11 |
| 2021-09-30 | $97M | 944k | 102.81 |
| 2021-06-30 | $99M | 1.1M | 87.96 |
| 2021-03-31 | $68M | 695k | 97.23 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management